help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishikawa, T.
Right arrow Articles by Ooi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishikawa, T.
Right arrow Articles by Ooi, A.

American Journal of Pathology, Vol 151, 761-768, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization

T Ishikawa, M Kobayashi, M Mai, T Suzuki and A Ooi
Department of Pathology, Faculty of Medicine, Kanazawa University, Ishikawa, Japan.

Amplification of the c-erbB-2 gene was examined in 120 gastric adenocarcinomas by dual-color fluorescence in situ hybridization (FISH) using probes for centromere 17 and the 17q11.2-12. The results were compared with Southern blot analysis and immunohistochemistry of c-erbB- 2 overexpression. FISH was successful in 105 tumors, and the amplification was found in 19 tumors. FISH on 17 tumors revealed high- level amplification; in 15, the predominant cancer populations had amplified c-erbB-2 gene with the signals forming one or two clusters, indicating that the amplified gene was present in homogeneously staining regions. In two tumors, most cancer cells had multiple scattered c-erbB-2 signals, indicating that the amplicon was within double-minute chromosomes. The other two tumors had a few additional copies of the c-erbB-2 gene. Seventeen tumors had increased numbers of the gene probably due to polysomy 17, and sixty-nine tumors had no aberrations of chromosome 17. Immunohistochemically, distinct membrane staining was found only in the 17 tumors with the high-level amplification. It is concluded that, in gastric adenocarcinomas, high- level amplification produces the c-erbB-2 gene principally in homogeneously staining region form and occasionally in double-minute form and is thought to control the over-expression of the protein in the cytoplasmic membrane.


This article has been cited by other articles:


Home page
Ann OncolHome page
H. Kim, T. Yoo, D. Park, J. Park, Y. Cho, C. Sohn, W. Jeon, B. Kim, M. Kim, S. Chae, et al.
Gene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochemistry: its prognostic implication in node-positive patients
Ann. Onc., May 1, 2007; 18(5): 892 - 897.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
M. Kimura, H. Tsuda, D. Morita, E. Shinto, T. Tanimoto, T. Ichikura, H. Mochizuki, and O. Matsubara
Usefulness and Limitation of Multiple Endoscopic Biopsy Sampling for Epidermal Growth Factor Receptor and c-erbB-2 Testing in Patients with Gastric Adenocarcinoma
Jpn. J. Clin. Oncol., June 1, 2005; 35(6): 324 - 331.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Kono, A. Takahashi, H. Sugai, H. Fujii, A. R. Choudhury, R. Kiessling, and Y. Matsumoto
Dendritic Cells Pulsed with HER-2/neu-derived Peptides Can Induce Specific T-Cell Responses in Patients with Gastric Cancer
Clin. Cancer Res., November 1, 2002; 8(11): 3394 - 3400.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. J. Khan, B. L. King, B. D. Smith, G. L. Smith, M. P. DiGiovanna, D. Carter, and B. G. Haffty
Characterization of the HER-2/neu Oncogene by Immunohistochemical and Fluorescence in Situ Hybridization Analysis in Oral and Oropharyngeal Squamous Cell Carcinoma
Clin. Cancer Res., February 1, 2002; 8(2): 540 - 548.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-i. Ohta, Y. Miyoshi, H. Uemura, K. Fujinami, K. Mikata, M. Hosaka, Y. Tokita, and Y. Kubota
Fluorescence in Situ Hybridization Evaluation of c-erbB-2 Gene Amplification and Chromosomal Anomalies in Bladder Cancer
Clin. Cancer Res., August 1, 2001; 7(8): 2463 - 2467.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
J Nicholson, C Wickramasinghe, F Ross, J Crolla, and D Ellison
Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation
Mol. Pathol., December 1, 2000; 53(6): 313 - 319.
[Abstract] [Full Text]


Home page
INT J SURG PATHOLHome page
M. Oya, T. Yao, and M. Tsuneyoshi
Numerical Chromosomal Aberration in NodePositive Early Gastric Carcinomas: Analysis by Fluorescence in Situ Hybridization and Immunohistochemical Staining
International Journal of Surgical Pathology, October 1, 1998; 6(4): 189 - 196.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. R. Andrechek, W. R. Hardy, P. M. Siegel, M. A. Rudnicki, R. D. Cardiff, and W. J. Muller
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
PNAS, March 28, 2000; 97(7): 3444 - 3449.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.